0001140361-24-010241.txt : 20240228
0001140361-24-010241.hdr.sgml : 20240228
20240228210046
ACCESSION NUMBER: 0001140361-24-010241
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240226
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossman Jerrold B
CENTRAL INDEX KEY: 0001542519
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36728
FILM NUMBER: 24698427
MAIL ADDRESS:
STREET 1: 65 COMMERCE WAY
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001368514
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 562590442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O ADMA BIOLOGICS, INC.
STREET 2: 465 STATE ROUTE 17
CITY: RAMSEY
STATE: NJ
ZIP: 07446
BUSINESS PHONE: (201) 478-5552
MAIL ADDRESS:
STREET 1: C/O ADMA BIOLOGICS, INC.
STREET 2: 465 STATE ROUTE 17
CITY: RAMSEY
STATE: NJ
ZIP: 07446
FORMER COMPANY:
FORMER CONFORMED NAME: R&R ACQUISITION VI, INC
DATE OF NAME CHANGE: 20060707
4
1
form4.xml
FORM 4
X0508
4
2024-02-26
0001368514
ADMA BIOLOGICS, INC.
ADMA
0001542519
Grossman Jerrold B
C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
RAMSEY
NJ
07446
true
false
Common Stock
2024-02-26
4
A
0
24040
0
A
467305
D
Common Stock
22857
I
See Footnote
Common Stock
31381
I
See Footnote
Common Stock
38294
I
See Footnote
Common Stock
175
I
See Footnote
Stock Option (right to buy)
5.4
2024-02-26
4
A
0
37541
0
A
2034-02-26
Common Stock
37541
37541
D
These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
Includes, as of the transaction date, (i) 24,040 RSUs granted on February 26, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 25,815 RSUs granted on March 6, 2023, which will vest in full on March 6, 2024; and (iii) 417,450 shares of common stock owned by the reporting person.
These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
These shares are owned by the reporting person's wife.
The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.
/s/ Dr. Jerrold B. Grossman, by Brian Lenz as Attorney-in-fact
2024-02-28